Authors: Klossek, JM Laliberte, F Laliberte, MF Mounedji, N Bousquet, J

Citation: Jm. Klossek et al., Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long term treatment of perennial allergic rhinitis, RHINOLOGY, 39(1), 2001, pp. 17-22

Authors: Frossard, N Vital-Durand, D Mounedji, N Valleteau, A

Citation: N. Frossard et al., Duration of the antihistaminic effect after discontinuation of ebastine, ALLERGY, 56(6), 2001, pp. 553-557

Authors: Levy, DA Mounedji, N Noirot, C Leynadier, F

Citation: Da. Levy et al., Allergic sensitization and clinical reactions to latex, food and pollen inadult patients, CLIN EXP AL, 30(2), 2000, pp. 270-275

Authors: Frossard, N Benabdesselam, O Purohit, A Mounedji, N Pauli, G

Citation: N. Frossard et al., Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steadystate treatment in the skin of healthy volunteers, FUN CL PHAR, 14(4), 2000, pp. 409-413

Authors: Laliberte, F Laliberte, MF Lecart, S Bousquet, J Klossec, JM Mounedji, N

Citation: F. Laliberte et al., Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids, ALLERGY, 55(8), 2000, pp. 718-722